Roles of Protein Kinase R in Cancer: Potential As a Therapeutic Target

Overview

Journal Cancer Sci

Specialty Oncology

Date 2018 Feb 26

PMID 29478262

Citations 27

Authors

Takao Watanabe

Takeshi Imamura

Yoichi Hiasa

Affiliations

Soon will be listed here.

Abstract

Double-stranded (ds) RNA-dependent protein kinase (PKR) is a ubiquitously expressed serine/threonine protein kinase. It was initially identified as an innate immune antiviral protein induced by interferon (IFN) and activated by dsRNA. PKR is recognized as a key executor of antiviral host defense. Moreover, it contributes to inflammation and immune regulation through several signaling pathways. In addition to IFN and dsRNA, PKR is activated by multiple stimuli and regulates various signaling pathways including the mitogen-activated protein kinase (MAPK) and nuclear factor kappa-light-chain-enhancer of activated B cells pathways. PKR was initially thought to be a tumor suppressor as a result of its ability to suppress cell growth and interact with major tumor suppressor genes. However, in several types of malignant disease, such as colon and breast cancers, its role remains controversial. In hepatocellular carcinoma, hepatitis C virus (HCV) is the main cause of liver cancer, and PKR inhibits HCV replication, indicating its role as a tumor suppressor. However, PKR is overexpressed in cirrhotic patients, and acts as a tumor promoter through enhancement of cancer cell growth by mediating MAPK or signal transducer and activator of transcription pathways. Moreover, PKR is reportedly required for the activation of inflammasomes and influences metabolic disorders. In the present review, we introduce the multifaceted roles of PKR such as antiviral function, tumor cell growth, regulation of inflammatory immune responses, and maintaining metabolic homeostasis; and discuss future perspectives on PKR biology including its potential as a therapeutic target for liver cancer.

Citing Articles

PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.

Okujima Y, Watanabe T, Ito T, Inoue Y, Kasai Y, Imai Y Sci Rep. 2024; 14(1):27768.

PMID: 39532917 PMC: 11557841. DOI: 10.1038/s41598-024-75142-5.

The Versatile Roles of nc886, a Fascinating and Peculiar Regulatory Non-Coding RNA, in Cancer.

Jang J, Kang D, Lee Y, Lee Y Int J Mol Sci. 2024; 25(19).

PMID: 39409154 PMC: 11476670. DOI: 10.3390/ijms251910825.

Sterile activation of RNA-sensing pathways in autoimmunity.

Li J, Zhu J, Yang H, Hou F J Mol Cell Biol. 2024; 16(7).

PMID: 39143032 PMC: 11659683. DOI: 10.1093/jmcb/mjae029.

Activation of protein kinase receptor (PKR) plays a pro-viral role in mammarenavirus-infected cells.

Witwit H, Khafaji R, Salaniwal A, Kim A, Cubitt B, Jackson N J Virol. 2024; 98(3):e0188323.

PMID: 38376197 PMC: 10949842. DOI: 10.1128/jvi.01883-23.

Eukaryotic translation initiation factor 2α kinase 2 in pancreatic cancer: An approach towards managing clinical prognosis and molecular immunological characterization.

Du H, Wang H, Ma X, Chen H, Dai A, Zhu K Oncol Lett. 2023; 26(5):478.

PMID: 37818134 PMC: 10561166. DOI: 10.3892/ol.2023.14066.

References

Blalock W, Grimaldi C, Fala F, Follo M, Horn S, Basecke J . PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation. J Cell Physiol. 2009; 221(1):232-41. DOI: 10.1002/jcp.21848. View

Wong A, Tam N, Yang Y, Cuddihy A, Li S, Kirchhoff S . Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 1997; 16(6):1291-304. PMC: 1169727. DOI: 10.1093/emboj/16.6.1291. View

Kim S, Forman A, Mathews M, Gunnery S . Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene. 2000; 19(27):3086-94. DOI: 10.1038/sj.onc.1203632. View

Goh K, deVeer M, Williams B . The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 2000; 19(16):4292-7. PMC: 302024. DOI: 10.1093/emboj/19.16.4292. View

Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundback P . Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 2012; 488(7413):670-4. PMC: 4163918. DOI: 10.1038/nature11290. View

Koromilas A, Roy S, Barber G, Katze M, Sonenberg N . Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science. 1992; 257(5077):1685-9. DOI: 10.1126/science.1382315. View

Hiasa Y, Kamegaya Y, Nuriya H, Onji M, Kohara M, Schmidt E . Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol. 2003; 98(11):2528-34. DOI: 10.1111/j.1572-0241.2003.08663.x. View

Yoon C, Lee E, Lim D, Bae Y . PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc Natl Acad Sci U S A. 2009; 106(19):7852-7. PMC: 2683089. DOI: 10.1073/pnas.0812148106. View

Donze O, Picard D . The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. EMBO J. 2001; 20(14):3771-80. PMC: 125551. DOI: 10.1093/emboj/20.14.3771. View

10.

He Y, Correa A, Raso M, Hofstetter W, Fang B, Behrens C . The role of PKR/eIF2α signaling pathway in prognosis of non-small cell lung cancer. PLoS One. 2011; 6(11):e24855. PMC: 3213082. DOI: 10.1371/journal.pone.0024855. View

11.

Bonnet M, Weil R, Dam E, Hovanessian A, Meurs E . PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex. Mol Cell Biol. 2000; 20(13):4532-42. PMC: 85837. DOI: 10.1128/MCB.20.13.4532-4542.2000. View

12.

Hii S, Hardy L, Crough T, Payne E, Grimmett K, Gill D . Loss of PKR activity in chronic lymphocytic leukemia. Int J Cancer. 2004; 109(3):329-35. DOI: 10.1002/ijc.11714. View

13.

Nakamura T, Furuhashi M, Li P, Cao H, Tuncman G, Sonenberg N . Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell. 2010; 140(3):338-48. PMC: 2820414. DOI: 10.1016/j.cell.2010.01.001. View

14.

Deb A, Xu Z, Kadereit S, Williams B . Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. EMBO J. 2001; 20(10):2487-96. PMC: 125453. DOI: 10.1093/emboj/20.10.2487. View

15.

Samuel C . Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci U S A. 1979; 76(2):600-4. PMC: 382996. DOI: 10.1073/pnas.76.2.600. View

16.

Sen G, Taira H, Lengyel P . Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells. J Biol Chem. 1978; 253(17):5915-21. View

17.

Takada Y, Ichikawa H, Pataer A, Swisher S, Aggarwal B . Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. Oncogene. 2006; 26(8):1201-12. DOI: 10.1038/sj.onc.1209906. View

18.

Gil J, Angel Garcia M, Esteban M . Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: molecular mechanism and relevance. FEBS Lett. 2002; 529(2-3):249-55. DOI: 10.1016/s0014-5793(02)03348-3. View

19.

Watanabe T, Hiasa Y, Tokumoto Y, Hirooka M, Abe M, Ikeda Y . Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection. PLoS One. 2013; 8(7):e67750. PMC: 3699507. DOI: 10.1371/journal.pone.0067750. View

20.

Barber G, Jagus R, Meurs E, Hovanessian A, Katze M . Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J Biol Chem. 1995; 270(29):17423-8. DOI: 10.1074/jbc.270.29.17423. View